WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there’s no good reason as to why. So now is the time to buy!

| More on:
healthcare pharma

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

WELL Health Technologies (TSX:WELL) has gotten a bad wrap over the past few years. WELL stock originally soared in the early days of the pandemic. As a telehealth provider, it was one of the companies that proved invaluable during stay-at-home orders.

However, when a vaccine became available, and tech stocks started to fall, WELL stock fell as well. But was the drop really deserving?

In short: No

WELL stock fell because its in the tech industry, a new company on the stock market, and a pandemic stock. That’s it. In short, there is no tangible reason why the company should have been dropped the way it was.

So after climbing 1,843% between January 2019 and February 2021, shares started plummeting. As of writing, WELL stock is down 68% from those all-time highs. Sure, it’s still a new stock, and it definitely got a push during the pandemic, but overall it’s still a strong company. Let’s look at why.

Strength in numbers

One way you can see the value of WELL stock is by looking at its earnings reports. Not only are earnings still strong for the company, they continue to report record-setting earnings quarter after quarter.

Most recently, WELL stock reported a 127% increase in revenue year over year to $140.3 million. It achieved adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $26.4 million, and net income of $17.2 million compared to a loss the year before.

What’s more, the company increased its annual revenue guidance for the third straight quarter. It now expects revenue to exceed $550 million, up from $525 million. WELL should therefore generate about $100 million in adjusted EBITDA.

Fundamentally strong

So the company is growing rapidly, both in profit and market presence. Management continues to raise guidance, and WELL now spans from Canada into the United States. And yet it’s still so incredibly valuable at today’s prices!

WELL stock offers a price-to-book ratio of just 0.96 as of writing. Further, it has a solid balance sheet, with just 47.9% of its equity needed to pay off all its debts. That’s after this major share drop!

Economists continue to drool over the stock, and its long-term potential. Telehealth is here to stay, and continues to expand. WELL stock meanwhile is now Canada’s largest outpatient clinic! So that puts it at the top of the list when it comes to future potential for growth in this space.

Bottom line

WELL stock is an incredibly valuable stock to pick up right now. It offers stability, has a solid balance sheet, continues to grow both organically and through acquisitions, and trades at a low price. In fact, within a year from now this stock could double your returns.

How do I know? Consider if WELL shares were to return to 52-week highs, when they traded at $7.18. Right now, shares are only at $2.96. That’s a potential upside of 143%! Even if you have only a little cash on hand, WELL stock fits into practically any portfolio. Especially for those willing to wait a year to see this company make a major turnaround.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in WELL Health Technologies Corp. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

telehealth stocks
Tech Stocks

The Ultimate Growth Stock to Buy With $100 Right Now

After climbing 600%, this growth stock is now down 68%. But it won't be long before other investors catch on.

Read more »